Wu Zuze, male, Han nationality, is native of Zhenhai, Zhejiang Province. He graduated from Shandong University in 1957 and is an experimental blood specialist.
Wu's academic achievements include research on double phase character mechanisms. He illustrated that a double phase character mechanism existed between radiation damage and accumulated irradiation doses under continuous irradiation of acute and low dose rate "g" rays. His studies led to animals being verified in a disease course of sequent radioactive accidental cases.
He also applied chromosome and sex determination genes as genetics markers, unveiled the unevenness of hematogenous stem cell group and researched the performance and dynamics of liver hematogenous stem cell in human embryo development. His studies provided a theoretical basis for clinic transplant embryo liver hematogenous stem cell. In addition, he proved that there were three kinds of factors, hematogenous stimulating factor, liver cell growth factor and low modular tumor prohibitor existing in embryo liver. He was the first to achieve liver cell growth factor from a human liver with molecular weight of 13 thousand Doulton. Most recently, he developed an experimental treatment for multiple gene tumors, such as P53, B7-1 and GM-CSF.
He has served as a researcher at the Military Academy of Medical Sciences and was elected as an academician to the Chinese Academy of Sciences in 1993.